Polymorphous low-grade adenocarcinoma: A Danish national study

Area of Science:

• Oncology
• Pathology
• Surgical Oncology

Background:

• Polymorphous low-grade adenocarcinoma (PLGA) is a rare salivary gland malignancy.
• Understanding its prognostic factors and survival outcomes is crucial for effective patient management.

Purpose of the Study:

• To analyze survival rates and prognostic factors in a national cohort of polymorphous low-grade adenocarcinoma (PLGA) patients.
• To provide evidence-based recommendations for the treatment of PLGA.

Main Methods:

• A national series of 73 PLGA patients diagnosed between 1990 and 2005 was identified by merging Danish registries.
• Histological review and data retrieval on demographics, tumor site, stage, treatment, and follow-up were performed.
• Kaplan-Meier plots and log-rank tests were used to evaluate survival estimates and prognostic factors.

Main Results:

• The most common tumor site was the palate (73%).
• Ten-year survival rates were: Overall Survival (OS) 73%, Disease-Specific Survival (DSS) 99%, and Recurrence-Free Survival (RFS) 83%.
• Free resection margins were associated with significantly improved RFS.

Conclusions:

• PLGA generally exhibits excellent survival outcomes, even in advanced stages or with locoregional recurrence.
• Complete surgical excision is the recommended primary treatment.
• Adjuvant radiotherapy may be considered for involved margins or advanced disease; late recurrences are common and treatable with salvage therapy.